These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28690499)

  • 1. Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson's Disease.
    Zhang X; Yang R; Hu BL; Lu P; Zhou LL; He ZY; Wu HM; Zhu JH
    Front Cell Neurosci; 2017; 11():170. PubMed ID: 28690499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.
    Chen Q; Deng N; Lu K; Liao Q; Long X; Gou D; Bi F; Zhou J
    Sci Rep; 2021 Jul; 11(1):15268. PubMed ID: 34315950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease.
    Zhao N; Jin L; Fei G; Zheng Z; Zhong C
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1177-80. PubMed ID: 25218846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary comparison of plasma notch-associated microRNA-34b and -34c levels in drug naive, first episode depressed patients and healthy controls.
    Sun N; Lei L; Wang Y; Yang C; Liu Z; Li X; Zhang K
    J Affect Disord; 2016 Apr; 194():109-14. PubMed ID: 26807671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.
    Miñones-Moyano E; Porta S; Escaramís G; Rabionet R; Iraola S; Kagerbauer B; Espinosa-Parrilla Y; Ferrer I; Estivill X; Martí E
    Hum Mol Genet; 2011 Aug; 20(15):3067-78. PubMed ID: 21558425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.
    Kabaria S; Choi DC; Chaudhuri AD; Mouradian MM; Junn E
    FEBS Lett; 2015 Jan; 589(3):319-25. PubMed ID: 25541488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson's Disease: A Potential Disease Biomarker.
    Yang Z; Li T; Cui Y; Li S; Cheng C; Shen B; Le W
    Front Neurosci; 2019; 13():218. PubMed ID: 30936821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Expression Levels of MicroRNA-132 and Nurr1 in Peripheral Blood of Parkinson's Disease: Potential Disease Biomarkers.
    Yang Z; Li T; Li S; Wei M; Qi H; Shen B; Chang RC; Le W; Piao F
    ACS Chem Neurosci; 2019 May; 10(5):2243-2249. PubMed ID: 30817108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.
    Li N; Pan X; Zhang J; Ma A; Yang S; Ma J; Xie A
    Neurol Sci; 2017 May; 38(5):761-767. PubMed ID: 28181066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analyses identify differentially expressed micrornas in Parkinson's disease.
    Schulz J; Takousis P; Wohlers I; Itua IOG; Dobricic V; Rücker G; Binder H; Middleton L; Ioannidis JPA; Perneczky R; Bertram L; Lill CM
    Ann Neurol; 2019 Jun; 85(6):835-851. PubMed ID: 30990912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.
    Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA
    J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.
    Botta-Orfila T; Morató X; Compta Y; Lozano JJ; Falgàs N; Valldeoriola F; Pont-Sunyer C; Vilas D; Mengual L; Fernández M; Molinuevo JL; Antonell A; Martí MJ; Fernández-Santiago R; Ezquerra M
    J Neurosci Res; 2014 Aug; 92(8):1071-7. PubMed ID: 24648008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW; Wang TB; Tian YH; Zheng YG
    Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
    Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
    J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of serum miR-206 and miR-133b is associated with lung carcinogenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
    Wu J; Yang T; Li X; Yang Q; Liu R; Huang J; Li Y; Yang C; Jiang Y
    Toxicol Appl Pharmacol; 2013 Mar; 267(3):238-46. PubMed ID: 23337359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-133b is a potential diagnostic biomarker for Alzheimer's disease and has a neuroprotective role.
    Yang Q; Zhao Q; Yin Y
    Exp Ther Med; 2019 Oct; 18(4):2711-2718. PubMed ID: 31572518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-133b ameliorates axon degeneration induced by MPP(+) via targeting RhoA.
    Niu M; Xu R; Wang J; Hou B; Xie A
    Neuroscience; 2016 Jun; 325():39-49. PubMed ID: 27012608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
    Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
    Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.